Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction

BMC Family Practice
Simon SchwillMichel Wensing

Abstract

Novel oral anticoagulation (NOAC) has been introduced in recent years, but data on use in atrial fibrillation (AF) in primary care setting is scarce. In Germany, General Practitioners are free to choose type of oral anticoagulation (OAC) in AF. Our aim was to explore changes in prescription-rates of OAC in German primary care before and after introduction of NOAC on the market. Data of a representative morbidity registration project in primary care in Germany (CONTENT) were analysed. Patients with AF in 2011 or 2014 were included (before and after broad market authorization of NOAC, respectively). We defined three independent groups: patients from 2011 without follow-up (group A), patients from 2014 but without previous record in 2011 (group B) and patients with AF and records in 2011 and 2014 (group C). 2642 patients were included. Group A (n = 804) and B (n = 755) were comparable regarding patient characteristics. 87.3% of group A and 84.8% of group B had CHA2DS2-VASc-Score ≥ 2, indicating a need for oral anticoagulation (OAC). Prescription of OAC increased from 23.1% (n = 186) to 42.8% (n = 323, p < .01) with stable use of vitamin-k-antagonist (22.6-24.9%). NOAC increased from 0.6 to 19.2% (p < .01). Monotherapy with Acetyls...Continue Reading

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Mar 11, 2006·European Heart Journal·Jan HeeringaJacqueline C M Witteman
Jan 12, 2012·Circulation. Cardiovascular Quality and Outcomes·Jonathan P PicciniLesley H Curtis
Dec 19, 2013·Circulation·Sumeet S ChughChristopher J L Murray
Jan 31, 2014·European Journal of Internal Medicine·Sabrina MuellerThomas Wilke
Apr 29, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·John RobsonKambiz Boomla
Feb 24, 2015·European Journal of Preventive Cardiology·Fd Richard HobbsUNKNOWN European Primary Care Cardiovascular Society (EPCCS) SPAF working group
Feb 3, 2016·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan Beyer-WestendorfThomas Evers

❮ Previous
Next ❯

Citations

Mar 14, 2020·Journal of Clinical Pharmacy and Therapeutics·Rashmi R Shah
Apr 16, 2020·International Journal of Clinical Pharmacy·Nijole BernaitisAdam La Caze
Nov 25, 2020·British Journal of Clinical Pharmacology·Folgerdiena M de VriesMonique M B Breteler
Dec 23, 2021·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Maxim GrymonprezLies Lahousse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.